John W. Bristol & Co’s Pfizer PFE Stock Holding History

John W. Bristol & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,070	Closed	-$452K	–	82
2023 Q1	$452K	Hold	11,070	–	–	0.01%	74
2022 Q4	$567K	Sell	11,070 -428	-4%	-$20.5K	0.01%	65
2022 Q3	$503K	Buy	11,498 +428	+4%	+$20.8K	0.01%	69
2022 Q2	$580K	Hold	11,070	–	–	0.01%	65
2022 Q1	$573K	Hold	11,070	–	–	0.01%	68
2021 Q4	$654K	Hold	11,070	–	–	0.01%	71
2021 Q3	$476K	Hold	11,070	–	–	0.01%	76
2021 Q2	$434K	Hold	11,070	–	–	0.01%	79
2021 Q1	$401K	Hold	11,070	–	–	0.01%	78
2020 Q4	$407K	Sell	11,070 -598	-5%	-$21.9K	0.01%	67
2020 Q3	$406K	Buy	+11,668	New	+$409K	0.01%	65
2019 Q1	–	Sell	-5,546	Closed	-$230K	–	82
2018 Q4	$230K	Buy	5,546 +12	+0.2%	+$498	0.01%	68
2018 Q3	$231K	Hold	5,534	–	–	0.01%	63
2018 Q2	$190K	Hold	5,534	–	–	0.01%	71
2018 Q1	$186K	Buy	+5,534	New	+$190K	0.01%	72

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

John W. Bristol & Co's PFE Position: Q2 2023 in Review

John W. Bristol & Co sold out of Pfizer (PFE) in Q2 2023, closing a stake of 11,070 shares — an estimated $452K sold.

John W. Bristol & Co first reported a position in PFE in Q1 2018 and held it in 15 quarters. The position peaked at $654K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

John W. Bristol & Co reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
John W. Bristol & Co sold 11,070 Pfizer shares in Q2 2023, an estimated $452K.
John W. Bristol & Co first reported a position in Pfizer in Q1 2018 and held it in 15 quarters.
John W. Bristol & Co's Pfizer position peaked at $654K in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on John W. Bristol & Co's 13F filing for Q2 2023, filed 28 Jul 2023.